CSF2 and liver disorder: Bone marrow hyperplasia was reported in hypertensive patients with cirrhosis and hypersplenism [19], while serum levels of M-CSF and GM-CSF were significantly reduced by subtotal splenectomy in cirrhosis patients with splenomegaly secondary to portal hypertension [20].